Professional
Added to YB: 2026-03-20
Pitch date: 2026-01-27
ZTS [bullish]
Zoetis Inc.
-6.48%
current return
Author Info
No bio for this author
Company Info
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
Market Cap
$51.4B
Pitch Price
$124.03
Price Target
N/A
Dividend
1.74%
EV/EBITDA
13.98
P/E
20.21
EV/Sales
6.17
Sector
Pharmaceuticals
Category
value
Diamond Hill Mid Cap Strategy New Position: Zoetis Inc.
ZTS (new position): Leader in animal health w/ broad portfolio for companion animals & livestock. Strong pipeline targeting undertreated pet conditions. Multiple growth drivers. Recent price pressure from concerns over dog arthritis drug created entry point below intrinsic value estimate.
Read full article (1 min)